Special Issue "Personalized Medicine in Otolaryngology: Special Topic Otology"
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 15894
Special Issues, Collections and Topics in MDPI journals
In collaboration with Journal of Personalized Medicine (IF: 4.945), in my capacity as Guest Editor I am helping to organize a Special Issue entitled “Personalized Medicine in Otolaryngology: Otology”. Globally, more than 1.5 billion people experience some degree of hearing loss. Of these, an estimated 432 million adults and 34 million children suffer from disabling hearing loss, that is, hearing loss of moderate or higher severity in the better hearing ear (WHO World report on hearing 2021). Disabling hearing loss and no benefit from conventional hearing aids are essential indications for implantable hearing systems, and the hearing threshold, the underlying pathology, and the anatomical conditions of the patients dictate the type of hearing implant indicated.
This Special Issue on otology aims to give a broad overview of personalized hearing rehabilitation across all ages and indications (very young children, adults, and very old adults), different applications, as well as necessary rehabilitation options. The title is kept broad to cover all aspects of personalized treatment options and their positive impact on a patient’s quality of life, from auditory brainstem implants to cochlear implants, bone conduction implants, and middle-ear implants.
In the past several decades, the technology behind all the above-mentioned hearing implants has developed immensely. This Special Issue on otology aims to discuss and broadcast some of the recent achievements and even provide a perspective on future developments in hearing technology.
Prof. Dr. Georg Mathias Sprinzl
Dr. Astrid Magele
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cochlear implants in children, adults and older adults
- active middle-ear implants in children, adults and the elderly
- new indications in otology
- active transcutaneous bone conduction implants in children, adults, and the elderly
- hearing loss and cholesteatoma
- implantable and non-implantable solutions for malformations
- age-related hearing loss
- single-sided deafness
- cochlear implantation
- otitis media
- quality of life
- burden of hearing loss
- genetics and epigenetics of hearing loss
- robotic surgery
- novel biomarkers for diagnosis and prognosis of hearing loss
- novel intra-operative objective measures for hearing implants
- alternative treatment options to implantable devices